BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 24513318)

  • 1. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
    Zhou T; Zhou X; Xing D
    Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance.
    Feng L; Li K; Shi X; Gao M; Liu J; Liu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1261-71. PubMed ID: 24652715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
    Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
    Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
    Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and characterization of a triple functionalization of graphene oxide with Fe3O4, folic acid and doxorubicin as dual-targeted drug nanocarrier.
    Wang Z; Zhou C; Xia J; Via B; Xia Y; Zhang F; Li Y; Xia L
    Colloids Surf B Biointerfaces; 2013 Jun; 106():60-5. PubMed ID: 23434692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent graphene oxide via polymer grafting: an efficient nanocarrier for both hydrophilic and hydrophobic drugs.
    Kundu A; Nandi S; Das P; Nandi AK
    ACS Appl Mater Interfaces; 2015 Feb; 7(6):3512-23. PubMed ID: 25612470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model.
    Liu CW; Xiong F; Jia HZ; Wang XL; Cheng H; Sun YH; Zhang XZ; Zhuo RX; Feng J
    Biomacromolecules; 2013 Feb; 14(2):358-66. PubMed ID: 23286342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
    Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.
    Zhang L; Xia J; Zhao Q; Liu L; Zhang Z
    Small; 2010 Feb; 6(4):537-44. PubMed ID: 20033930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W; Zhou J; Mann A; Wang Y; Zhu L
    Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes.
    Lu YJ; Wei KC; Ma CC; Yang SY; Chen JP
    Colloids Surf B Biointerfaces; 2012 Jan; 89():1-9. PubMed ID: 21982868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalized Graphene Oxide with Hepatocyte Targeting as Anti-Tumor Drug and Gene Intracellular Transporters.
    Cao X; Zheng S; Zhang S; Wang Y; Yang X; Duan H; Huang Y; Chen Y
    J Nanosci Nanotechnol; 2015 Mar; 15(3):2052-9. PubMed ID: 26413620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic pH-responsive nanocarrier with long spacer length and high colloidal stability for controlled delivery of doxorubicin.
    Pourjavadi A; Hosseini SH; Alizadeh M; Bennett C
    Colloids Surf B Biointerfaces; 2014 Apr; 116():49-54. PubMed ID: 24441180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
    Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
    Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
    Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
    J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.